DexTech Medical AB
Developing pharmaceuticals for urological oncology using its proprietary GuaDex technology platform.
DEX | SPGR
Overview
Corporate Details
- ISIN(s):
- SE0005881489
- LEI:
- 549300O3OL7X6EWKLO53
- Country:
- Sweden
- Address:
- Box 389, 752 23 Uppsala
- Website:
- https://dextechmedical.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
DexTech Medical AB is a research company specializing in the development of pharmaceuticals for urological oncology, with a primary focus on prostate cancer. The company's drug candidates are based on its proprietary and patented GuaDex technology platform, a carbohydrate-drug-conjugate (CDC) system. Its pipeline includes drug candidates such as OsteoDex, SomaDex, CatDex, and PSMA-Dx. DexTech conducts translational research with a strong clinical foundation, possessing specialist expertise from pre-clinical research to clinical oncology and drug manufacturing process development. The GuaDex platform is also available for out-licensing for other specific applications.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all DexTech Medical AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for DexTech Medical AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
